Members of Programme Group are authors and co-authors of international patents on a) New technology: Particles of spherically agglomerated lactose for direct compression and method of preparation thereof (patent no.: US 10,568,837 B2. Alexandria: United States Patent and Trademark Office, 2020). [COBISS.SI-ID 4902769] Many active pharmaceutical ingredients are not directly compressible, therefore addition of pharmaceutical excipients is necessary. Fillers are essential pharmaceutical excipients, among which sugars are commonly employed, especially lactose. It is required that such substances have good flowability and compressibility. The present invention enables a simple and industry applicable production of particles of spherically agglomerated lactose that have suitable flow properties, excellent compression characteristics and reduce or prevent occurrence of segregation in mixture for production of solid dosage forms. b) Dissolution device : International Publication number WO 2020/05842 A1. Geneva: World Intellectual Property Organization, 2020. [COBISS.SI-ID 4902513] A dissolution device for measuring a dissolution rate of a test sample in a fluid, the device comprising a first cavity and a second cavity, wherein each of the first and second cavities has a fluid inlet for connection to a fluid supply, and wherein the device comprises an opening between the first and second cavities, and the device comprises a sample support configured to position the test sample across the opening.
F.32 International patent
COBISS.SI-ID: 4902769Some members of the Programme Group were guest editors or coeditors of thematic issues of two highly ranked journals in the field of pharmaceutical sciences: a) European Journal of Pharmaceutcial Sciences: Approaches of molecular modifications, self-assembled, structured particles and manufacturing with digital blueprint in service of advanced drug delivery design b) M Kerec Kos in T Vovk were in the years 2018 in 2019 guest editors of the thematic issues of the journal Farmacevtski vestnik: 2018, št. 1, Klinična farmacija (M Kerec Kos, T Vovk) 2018, št. 2, Hrana, razvade in zdravila, okužbe (M Kerec Kos) 2018, št. 4, Izdelki iz zdravilnih rastlin (M Kerec Kos) 2019, št. 2, Ščitnica, osteopenija in osteoporoza, anemije, parodontalna bolezen (T Vovk) 2019, št. 4, Zdravila in jetra (M Kerec Kos).
C.03 Guest-associated editor
COBISS.SI-ID: 4873841Some members of the Programme Group had invited lectures in this last period of time: a) Precision coating of particle, mini tablets and tablets, Dreu Rok, 13th PSSRC Annual Meeting, Düsseldorf, Germany, [COBISS.SI-ID 4841329 b) Kinetically frozen emulsion systems for oral delivery of drugs with low solubility and permeability, Dreu Rok, 8th BBBB International Conference, [COBISS.SI-ID 4831089]. c) Lipid based drug delivery systems formulations I & II; Microencapsulation and other solidification techniques for lipid based formulations I&II, Zvonar Pobirk Alenka, PhD School in Chemistry joint between Universty of Trieste and Ca` Foscari University in Venice; ([COBISS.SI-ID 4683121]; [COBISS.SI-ID 4696945]; [COBISS.SI-ID 4683377]; [COBISS.SI-ID 4696689])
B.04 Guest lecture
COBISS.SI-ID: 4831089a) In the period from 1/1/2018 - 31/3/2020 PhD Students supervised by Programme Group members were honoured by a number of highly prestigious awards, namely: 2 Krka Prizes for special achievements in research; Špela Zupančič (2018), mentor Julijana Kristl; Klemen Korasa (2019), mentor Franc Vrečer 'Small' Krka prizes: Ina Kosmač (2018), mentor A Zvonar Pobirk b) FFA awards for life achievements: A Mrhar, J Kristl, S Srčič c) Prometej scientific award for excellency in communication (Slovene Science Foundation) for 2017: A Zvonar Pobirk
E.01 National awards
COBISS.SI-ID: 4628849Background Medication review is important in an era, in which polypharmacy is increasing. To date, no agreed international definition of medication review exists. Objective The aim was to reach agreement on an internationally applicable definition of medication review. Setting An international group of experts in medication review. Methods A working group of the Pharmaceutical Care Network Europe (PCNE) was established to agree on a definition including a classification of medication review. First, a survey with the aim of systematically gathering viewpoints on a definition of medication review was conducted. Second, a workshop was held to achieve an agreement. Finally, during the General Assembly of PCNE, the definition was approved. To ensure a better understanding of the scope and the considerations behind the definition, a position paper was created. Main outcome measure An internationally agreed definition of medication review. Results 58 PCNE members from 20 different countries completed the online survey. Then, 22 participants from 11 different countries (not only PCNE members) elaborated the final definition during a workshop. The final PCNE version agreed was: %Medication review is a structured evaluation of a patient%s medicines with the aim of optimising medicines use and improving health outcomes. This entails detecting drug-related problems and recommending interventions%. Overall, the consensus process included 225 people from 35 countries and resulted also in...
F.12 Improvements to an existing service
COBISS.SI-ID: 4555121